|
C1ORF107 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.770800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.228400E-01 |
| Normal-vs-Stage2 |
7.756000E-01 |
| Normal-vs-Stage3 |
9.118200E-02 |
| Normal-vs-Stage4 |
2.778600E-01 |
| Stage1-vs-Stage2 |
4.134400E-01 |
| Stage1-vs-Stage3 |
3.724200E-02 |
| Stage1-vs-Stage4 |
6.338400E-02 |
| Stage2-vs-Stage3 |
2.519600E-01 |
| Stage2-vs-Stage4 |
3.457200E-01 |
| Stage3-vs-Stage4 |
9.508400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.470200E-01 |
| Normal-vs-AfricanAmerican |
8.289200E-01 |
| Normal-vs-Asian |
7.559600E-01 |
| Caucasian-vs-AfricanAmerican |
5.876200E-01 |
| Caucasian-vs-Asian |
6.819200E-01 |
| AfricanAmerican-vs-Asian |
8.034600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.532800E-01 |
| Normal-vs-Female |
3.702000E-03 |
| Male-vs-Female |
1.775010E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.715600E-01 |
| Normal-vs-Extreme_Weight |
5.550300E-02 |
| Normal-vs-Obese |
2.957600E-01 |
| Normal-vs-Extreme_Obese |
3.658800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.456200E-02 |
| Normal_Weight-vs-Obese |
7.694200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.509400E-01 |
| Extreme_Weight-vs-Obese |
1.811620E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.522400E-01 |
| Obese-vs-Extreme_Obese |
2.586200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.210300E-02 |
| Normal-vs-Age(41-60Yrs) |
4.209000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.957800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.446820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.772100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.433600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.686500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.464400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.057630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.013200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.650560E-01 |
| Normal-VS-Type2 PRCC |
2.814200E-01 |
| Normal-VS-KIRP CIMP |
6.328200E-02 |
| Normal-VS-Unclassified PRCC |
3.069800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.968500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.985600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.572000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.463700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.518000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.193200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.552200E-01 |
| Normal-vs-N1 |
5.897700E-03 |
| Normal-vs-N2 |
3.750000E-01 |
| N0-vs-N1 |
2.642500E-03 |
| N0-vs-N2 |
1.944350E-01 |
| N1-vs-N2 |
5.916800E-01 |
|
|
